ExecuPharm Inc

ExecuPharm Inc. is a pharmaceutical company headquartered in the United States of America. The firm operates within the pharmaceutical sector. Specific details about its product lines, services, or geographic reach are not provided in the available sources.

On March 13, 2020, ExecuPharm Inc. was targeted by a ransomware attack carried out by the CLOP group. The attackers exfiltrated a range of sensitive internal data, including employee Social Security numbers, financial records, passport details, corporate emails, and database backups. They later threatened to publish the stolen information unless a ransom was paid, alleging that the company had profited from the ongoing health crisis despite pandemic‑related pledges to spare medical facilities. In response, the firm engaged external cybersecurity experts, notified law enforcement and affected individuals, and initiated a formal investigation. The CLOP ransomware variant used in the incident does not have a publicly available decryption tool, highlighting the group's reliance on data‑leak extortion.

The provided sources do not disclose information regarding the company's ownership structure, parent or subsidiary relationships, workforce size, or annual revenue. Consequently, any description of its scale or corporate hierarchy remains unspecified. The profile is therefore limited to the confirmed facts about its sector, location, and the 2020 ransomware incident.